GELS
Gelteq Limited Ordinary Shares
NASDAQ: GELS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.66
+2.00% today
Updated 2026-05-01
Market cap
$6.91M
P/E ratio
—
P/S ratio
16.72x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
Gelteq Limited Ordinary Shares (GELS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | $619115.00 | $24.22M | $23.41M | $22.49M | $20.76M | $21.48M |
| Cash & equivalents | $319519.00 | $181664.00 | $162485.00 | $399224.00 | $24522.00 | $344648.00 |
| Current assets | $574497.00 | $374909.00 | $720065.00 | $990974.00 | $303227.00 | $1.51M |
| Total liabilities | $396043.00 | $403228.00 | $2.55M | $3.84M | $5.65M | $5.67M |
| Current liabilities | $229935.00 | $235900.00 | $1.08M | $1.36M | $3.87M | $5.63M |
| Long-term debt | — | $167328.00 | $1.46M | $2.47M | $1.76M | $13550.00 |
| Shareholder equity | $223072.00 | $23.82M | $20.86M | $18.66M | $15.11M | $15.80M |
| Retained earnings | $-460425.00 | $-1.11M | $-4.48M | $-7.95M | $-11.50M | $-18.14M |
| Accounts receivable | $254978.00 | $193245.00 | $250666.00 | $345291.00 | $183005.00 | $459724.00 |
| Inventory | — | $0.00 | $95201.00 | $95201.00 | $0.00 | — |
| Goodwill | — | — | — | — | — | — |